Abstract

Countries have varied enormously in how they have responded to the COVID-19 pandemic, ranging from elimination strategies (eg, Australia, New Zealand, Taiwan) to tight suppression (not aiming for elimination but rather to keep infection rates low [eg, South Korea]) to loose suppression (eg, Europe, United States) to virtually unmitigated (eg, Brazil, India). Weighing the best option, based on health and economic consequences due to lockdowns, is necessary. To determine the optimal policy response, using a net monetary benefit (NMB) approach, for policies ranging from aggressive elimination and moderate elimination to tight suppression (aiming for 1-5 cases per million per day) and loose suppression (5-25 cases per million per day). Using governmental data from the state of Victoria, Australia, and other collected data, 2 simulation models in series were conducted of all residents (population, 6.4 million) for SARS-CoV-2 infections for 1 year from September 1, 2020. An agent-based model (ABM) was used to estimate daily SARS-CoV-2 infection rates and time in 5 stages of social restrictions (stages 1, 1b, 2, 3, and 4) for 4 policy response settings (aggressive elimination, moderate elimination, tight suppression, and loose suppression), and a proportional multistate life table (PMSLT) model was used to estimate health-adjusted life-years (HALYs) associated with COVID-19 and costs (health systems and health system plus gross domestic product [GDP]). The ABM is a generic COVID-19 model of 2500 agents, or simulants, that was scaled up to the population of interest. Models were specified with data from 2019 (eg, epidemiological data in the PMSLT model) and 2020 (eg, epidemiological and cost consequences of COVID-19). The NMB of each policy option at varying willingness to pay (WTP) per HALY was calculated: NMB = HALYs × WTP - cost. The estimated most cost-effective (optimal) policy response was that with the highest NMB. Estimated SARS-CoV-2 infection rates, time under 5 stages of restrictions, HALYs, health expenditure, and GDP losses. In 100 runs of both the ABM and PMSLT models for each of the 4 policy responses, 31.0% of SARS-CoV-2 infections, 56.5% of hospitalizations, and 84.6% of deaths occurred among those 60 years and older. Aggressive elimination was associated with the highest percentage of days with the lowest level of restrictions (median, 31.7%; 90% simulation interval [SI], 6.6%-64.4%). However, days in hard lockdown were similar across all 4 strategies. The HALY losses (compared with a scenario without COVID-19) were similar for aggressive elimination (median, 286 HALYs; 90% SI, 219-389 HALYs) and moderate elimination (median, 314 HALYs; 90% SI, 228-413 HALYs), and nearly 8 and 40 times higher for tight suppression and loose suppression, respectively. The median GDP loss was least for moderate elimination (median, $41.7 billion; 90% SI, $29.0-$63.6 billion), but there was substantial overlap in simulation intervals between the 4 strategies. From a health system perspective, aggressive elimination was optimal in 64% of simulations above a WTP of $15 000 per HALY, followed by moderate elimination in 35% of simulations. Moderate elimination was optimal from a GDP perspective in half of the simulations, followed by aggressive elimination in a quarter. In this simulation modeling economic evaluation of estimated SARS-CoV-infection rates, time under 5 stages of restrictions, HALYs, health expenditure, and GDP losses in Victoria, Australia, an elimination strategy was associated with the least health losses and usually the fewest GDP losses.

Highlights

  • There is no best approach for all countries to follow when handling the COVID-19 pandemic

  • In 100 runs of both the agentbased model (ABM) and proportional multistate life table (PMSLT) models for each of the 4 policy responses, 31.0% of SARS-CoV-2 infections, 56.5% of hospitalizations, and 84.6% of deaths occurred among those 60 years and older

  • The median gross domestic product (GDP) loss was least for moderate elimination, but there was substantial overlap in simulation intervals between the 4 strategies

Read more

Summary

Introduction

There is no best approach for all countries to follow when handling the COVID-19 pandemic. One way to support this challenging decision-making is to use an integrated assessment of health and economic outcomes Such an optimization approach is often implicit in commentaries, with phrases such as ensuring the cure is not worse than the disease.[2] But seldom is this balance or optimization explicitly defined and empirically addressed. To this point in the pandemic, a standard cost-effectiveness analysis resting on epidemiological modeling has not been widely used with the exception of cost-effectiveness and cost-benefit studies looking at a narrow range of policy measures, such as social distancing, treatments, or a vaccine, or focused on a particular population group, such as testing strategies in the residential college campus setting.[3] Existing reviews[4] show a mix of methodologies evaluating a range of interventions, with studies evaluating broader policy measures among a wider population[5] being less common. Undertaking cost-effectiveness studies in a pandemic is challenging for reasons such as which perspective to use (eg, health system only or societal) and uncertainty in many inputs—yet, be it implicit or explicit, cost-effectiveness does feature in decision-making

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call